Clinical Trials for Cancer Treatment

Study Title:

Neurocognitive changes in breast cancer patients on hormonal therapy. Is there a difference between objective and perceived neurocognition?

What is the purpose of the study? (in Layman's terms, please describe the study)

To study the progressive neurocognitive changes in breast cancer patients started on HT (hormone therapy)

Upstate Institutional Review Board (IRB) Number:

1490316

Study/Protocol ID:

Neurocog HT

Study Phase:

N/A

Patient Age Group:

Adults

Principal Investigator:

Sam Benjamin, MD

Who is eligible?

Women who are Postmenopausal and are planned to start HT

What is involved if I participate?

• How long is the study?
  1 year
• Is transportation provided or reimbursed?
  No
• Is parking provided or reimbursed?
  No
• What tests and procedures are involved?
  Questionnaire type evaluations.

Where will the study take place?

Cancer Center all procedures

Other Information:

N/A

Who can I contact for more information?

Name: AMY BUBB
Phone: 315-464-5788
Email: [email protected]

Return to Previous Page || Search Again